Global Poliomyelitis Vaccation Market Research Report 2026(Status and Outlook)

May 2026 | 139 pages | ID: GCA929926DCAEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Poliomyelitis Vaccation competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.The poliomyelitis vaccine is a biological preparation used to provide immunity against poliovirus, the causative agent of poliomyelitis (commonly known as polio). There are two main types of polio vaccines: Inactivated Poliovirus Vaccine (IPV), which is injected, and Oral Poliovirus Vaccine (OPV), which is administered orally. These vaccines stimulate the immune system to produce antibodies that neutralize the virus and prevent infection.The Poliomyelitis Vaccine market is primarily driven by global initiatives aimed at eradicating polio, supported by organizations such as the World Health Organization (WHO), Gavi, and the Global Polio Eradication Initiative (GPEI). Routine immunization programs and mass vaccination campaigns in endemic and high-risk regions continue to sustain demand for both oral polio vaccines (OPV) and inactivated polio vaccines (IPV). Increasing government funding, public health awareness, and international collaboration have significantly boosted vaccination coverage, especially in low- and middle-income countries. Technological advancements in vaccine production and improved supply chain logistics are also contributing to steady market growth.Despite considerable progress, the market faces challenges such as the emergence of vaccine-derived poliovirus (VDPV) cases, which are associated with the use of OPV in under-immunized populations. This raises concerns about vaccine safety and requires careful transition strategies to IPV. Additionally, logistical barriers—including poor infrastructure, political instability, and limited healthcare access in remote or conflict-affected areas—hamper effective vaccine delivery. Vaccine hesitancy and misinformation in certain communities also threaten immunization efforts. Maintaining funding and momentum in a declining disease landscape remains a critical hurdle to achieving complete eradication and ensuring long-term market stability.

The global Poliomyelitis Vaccation market size was estimated at USD 144.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Poliomyelitis Vaccation market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Poliomyelitis Vaccation market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Poliomyelitis Vaccation market.

Global Poliomyelitis Vaccation Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

  • Sanofi
  • GSK
  • Bibcol
  • SerumInstitute(BilthovenBiologicals)
  • Tiantan Biological
  • IMBCA
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals
  • SINOVAC

Market Segmentation (by Type)

  • OPV
  • IPV

Market Segmentation (by Application)

  • Hospitals
  • Clinics
  • Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Poliomyelitis Vaccation Market

Overview of the regional outlook of the Poliomyelitis Vaccation Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliomyelitis Vaccation Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Poliomyelitis Vaccation, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Poliomyelitis Vaccation
1.2 Key Market Segments
  1.2.1 Poliomyelitis Vaccation Segment by Type
  1.2.2 Poliomyelitis Vaccation Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 POLIOMYELITIS VACCATION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Poliomyelitis Vaccation Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Poliomyelitis Vaccation Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 POLIOMYELITIS VACCATION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Poliomyelitis Vaccation Product Life Cycle
3.3 Global Poliomyelitis Vaccation Sales by Manufacturers (2020-2025)
3.4 Global Poliomyelitis Vaccation Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliomyelitis Vaccation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliomyelitis Vaccation Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Poliomyelitis Vaccation Market Competitive Situation and Trends
  3.8.1 Poliomyelitis Vaccation Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Poliomyelitis Vaccation Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 POLIOMYELITIS VACCATION INDUSTRY CHAIN ANALYSIS

4.1 Poliomyelitis Vaccation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF POLIOMYELITIS VACCATION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Poliomyelitis Vaccation Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Poliomyelitis Vaccation Market
5.7 ESG Ratings of Leading Companies

6 POLIOMYELITIS VACCATION MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliomyelitis Vaccation Sales Market Share by Type (2020-2025)
6.3 Global Poliomyelitis Vaccation Market Size by Type (2020-2025)
6.4 Global Poliomyelitis Vaccation Price by Type (2020-2025)

7 POLIOMYELITIS VACCATION MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliomyelitis Vaccation Market Sales by Application (2020-2025)
7.3 Global Poliomyelitis Vaccation Market Size (M USD) by Application (2020-2025)
7.4 Global Poliomyelitis Vaccation Sales Growth Rate by Application (2020-2025)

8 POLIOMYELITIS VACCATION MARKET SALES BY REGION

8.1 Global Poliomyelitis Vaccation Sales by Region
  8.1.1 Global Poliomyelitis Vaccation Sales by Region
  8.1.2 Global Poliomyelitis Vaccation Sales Market Share by Region
8.2 Global Poliomyelitis Vaccation Market Size by Region
  8.2.1 Global Poliomyelitis Vaccation Market Size by Region
  8.2.2 Global Poliomyelitis Vaccation Market Size by Region
8.3 North America
  8.3.1 North America Poliomyelitis Vaccation Sales by Country
  8.3.2 North America Poliomyelitis Vaccation Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Poliomyelitis Vaccation Sales by Country
  8.4.2 Europe Poliomyelitis Vaccation Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Poliomyelitis Vaccation Sales by Region
  8.5.2 Asia Pacific Poliomyelitis Vaccation Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Poliomyelitis Vaccation Sales by Country
  8.6.2 South America Poliomyelitis Vaccation Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Poliomyelitis Vaccation Sales by Region
  8.7.2 Middle East and Africa Poliomyelitis Vaccation Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 POLIOMYELITIS VACCATION MARKET PRODUCTION BY REGION

9.1 Global Production of Poliomyelitis Vaccation by Region(2020-2025)
9.2 Global Poliomyelitis Vaccation Revenue Market Share by Region (2020-2025)
9.3 Global Poliomyelitis Vaccation Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Poliomyelitis Vaccation Production
  9.4.1 North America Poliomyelitis Vaccation Production Growth Rate (2020-2025)
  9.4.2 North America Poliomyelitis Vaccation Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Poliomyelitis Vaccation Production
  9.5.1 Europe Poliomyelitis Vaccation Production Growth Rate (2020-2025)
  9.5.2 Europe Poliomyelitis Vaccation Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Poliomyelitis Vaccation Production (2020-2025)
  9.6.1 Japan Poliomyelitis Vaccation Production Growth Rate (2020-2025)
  9.6.2 Japan Poliomyelitis Vaccation Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Poliomyelitis Vaccation Production (2020-2025)
  9.7.1 China Poliomyelitis Vaccation Production Growth Rate (2020-2025)
  9.7.2 China Poliomyelitis Vaccation Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Sanofi
  10.1.1 Sanofi Basic Information
  10.1.2 Sanofi Poliomyelitis Vaccation Product Overview
  10.1.3 Sanofi Poliomyelitis Vaccation Product Market Performance
  10.1.4 Sanofi Business Overview
  10.1.5 Sanofi SWOT Analysis
  10.1.6 Sanofi Recent Developments
10.2 GSK
  10.2.1 GSK Basic Information
  10.2.2 GSK Poliomyelitis Vaccation Product Overview
  10.2.3 GSK Poliomyelitis Vaccation Product Market Performance
  10.2.4 GSK Business Overview
  10.2.5 GSK SWOT Analysis
  10.2.6 GSK Recent Developments
10.3 Bibcol
  10.3.1 Bibcol Basic Information
  10.3.2 Bibcol Poliomyelitis Vaccation Product Overview
  10.3.3 Bibcol Poliomyelitis Vaccation Product Market Performance
  10.3.4 Bibcol Business Overview
  10.3.5 Bibcol SWOT Analysis
  10.3.6 Bibcol Recent Developments
10.4 SerumInstitute(BilthovenBiologicals)
  10.4.1 SerumInstitute(BilthovenBiologicals) Basic Information
  10.4.2 SerumInstitute(BilthovenBiologicals) Poliomyelitis Vaccation Product Overview
  10.4.3 SerumInstitute(BilthovenBiologicals) Poliomyelitis Vaccation Product Market Performance
  10.4.4 SerumInstitute(BilthovenBiologicals) Business Overview
  10.4.5 SerumInstitute(BilthovenBiologicals) Recent Developments
10.5 Tiantan Biological
  10.5.1 Tiantan Biological Basic Information
  10.5.2 Tiantan Biological Poliomyelitis Vaccation Product Overview
  10.5.3 Tiantan Biological Poliomyelitis Vaccation Product Market Performance
  10.5.4 Tiantan Biological Business Overview
  10.5.5 Tiantan Biological Recent Developments
10.6 IMBCA
  10.6.1 IMBCA Basic Information
  10.6.2 IMBCA Poliomyelitis Vaccation Product Overview
  10.6.3 IMBCA Poliomyelitis Vaccation Product Market Performance
  10.6.4 IMBCA Business Overview
  10.6.5 IMBCA Recent Developments
10.7 Panacea Biotec Ltd
  10.7.1 Panacea Biotec Ltd Basic Information
  10.7.2 Panacea Biotec Ltd Poliomyelitis Vaccation Product Overview
  10.7.3 Panacea Biotec Ltd Poliomyelitis Vaccation Product Market Performance
  10.7.4 Panacea Biotec Ltd Business Overview
  10.7.5 Panacea Biotec Ltd Recent Developments
10.8 Bio-Med
  10.8.1 Bio-Med Basic Information
  10.8.2 Bio-Med Poliomyelitis Vaccation Product Overview
  10.8.3 Bio-Med Poliomyelitis Vaccation Product Market Performance
  10.8.4 Bio-Med Business Overview
  10.8.5 Bio-Med Recent Developments
10.9 Halfkin Bio-Pharmaceuticals
  10.9.1 Halfkin Bio-Pharmaceuticals Basic Information
  10.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccation Product Overview
  10.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccation Product Market Performance
  10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
  10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.10 SINOVAC
  10.10.1 SINOVAC Basic Information
  10.10.2 SINOVAC Poliomyelitis Vaccation Product Overview
  10.10.3 SINOVAC Poliomyelitis Vaccation Product Market Performance
  10.10.4 SINOVAC Business Overview
  10.10.5 SINOVAC Recent Developments

11 POLIOMYELITIS VACCATION MARKET FORECAST BY REGION

11.1 Global Poliomyelitis Vaccation Market Size Forecast
11.2 Global Poliomyelitis Vaccation Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Poliomyelitis Vaccation Market Size Forecast by Country
  11.2.3 Asia Pacific Poliomyelitis Vaccation Market Size Forecast by Region
  11.2.4 South America Poliomyelitis Vaccation Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Poliomyelitis Vaccation by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Poliomyelitis Vaccation Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Poliomyelitis Vaccation by Type (2026-2035)
  12.1.2 Global Poliomyelitis Vaccation Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Poliomyelitis Vaccation by Type (2026-2035)
12.2 Global Poliomyelitis Vaccation Market Forecast by Application (2026-2035)
  12.2.1 Global Poliomyelitis Vaccation Sales (K MT) Forecast by Application
  12.2.2 Global Poliomyelitis Vaccation Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliomyelitis Vaccation Market Size by Type (M USD)
Table 4. Global Poliomyelitis Vaccation Market Size by Application
Table 5. Poliomyelitis Vaccation Market Size Comparison by Region (M USD)
Table 6. Global Poliomyelitis Vaccation Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliomyelitis Vaccation Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliomyelitis Vaccation Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliomyelitis Vaccation Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccation as of 2025)
Table 11. Global Market Poliomyelitis Vaccation Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Poliomyelitis Vaccation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliomyelitis Vaccation Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Poliomyelitis Vaccation Sales by Type (K MT)
Table 27. Global Poliomyelitis Vaccation Market Size by Type (M USD)
Table 28. Global Poliomyelitis Vaccation Sales (K MT) by Type (2020-2025)
Table 29. Global Poliomyelitis Vaccation Sales Market Share by Type (2020-2025)
Table 30. Global Poliomyelitis Vaccation Market Size (M USD) by Type (2020-2025)
Table 31. Global Poliomyelitis Vaccation Market Share by Type (2020-2025)
Table 32. Global Poliomyelitis Vaccation Price (USD/KG) by Type (2020-2025)
Table 33. Global Poliomyelitis Vaccation Sales (K MT) by Application
Table 34. Global Poliomyelitis Vaccation Market Size by Application
Table 35. Global Poliomyelitis Vaccation Sales by Application (2020-2025) & (K MT)
Table 36. Global Poliomyelitis Vaccation Sales Market Share by Application (2020-2025)
Table 37. Global Poliomyelitis Vaccation Market Size by Application (2020-2025) & (M USD)
Table 38. Global Poliomyelitis Vaccation Market Share by Application (2020-2025)
Table 39. Global Poliomyelitis Vaccation Sales Growth Rate by Application (2020-2025)
Table 40. Global Poliomyelitis Vaccation Sales by Region (2020-2025) & (K MT)
Table 41. Global Poliomyelitis Vaccation Sales Market Share by Region (2020-2025)
Table 42. Global Poliomyelitis Vaccation Market Size by Region (2020-2025) & (M USD)
Table 43. Global Poliomyelitis Vaccation Market Size by Region (2020-2025)
Table 44. North America Poliomyelitis Vaccation Sales by Country (2020-2025) & (K MT)
Table 45. North America Poliomyelitis Vaccation Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Poliomyelitis Vaccation Sales by Country (2020-2025) & (K MT)
Table 47. Europe Poliomyelitis Vaccation Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Poliomyelitis Vaccation Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Poliomyelitis Vaccation Market Size by Region (2020-2025) & (M USD)
Table 50. South America Poliomyelitis Vaccation Sales by Country (2020-2025) & (K MT)
Table 51. South America Poliomyelitis Vaccation Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Poliomyelitis Vaccation Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Poliomyelitis Vaccation Market Size by Region (2020-2025) & (M USD)
Table 54. Global Poliomyelitis Vaccation Production (K MT) by Region(2020-2025)
Table 55. Global Poliomyelitis Vaccation Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Poliomyelitis Vaccation Revenue Market Share by Region (2020-2025)
Table 57. Global Poliomyelitis Vaccation Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Poliomyelitis Vaccation Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Poliomyelitis Vaccation Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Poliomyelitis Vaccation Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Poliomyelitis Vaccation Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Poliomyelitis Vaccation Product Overview
Table 64. Sanofi Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Poliomyelitis Vaccation Product Overview
Table 70. GSK Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Poliomyelitis Vaccation Product Overview
Table 76. Bibcol Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. SerumInstitute(BilthovenBiologicals) Basic Information
Table 81. SerumInstitute(BilthovenBiologicals) Poliomyelitis Vaccation Product Overview
Table 82. SerumInstitute(BilthovenBiologicals) Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. SerumInstitute(BilthovenBiologicals) Business Overview
Table 84. SerumInstitute(BilthovenBiologicals) Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Poliomyelitis Vaccation Product Overview
Table 87. Tiantan Biological Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Basic Information
Table 91. IMBCA Poliomyelitis Vaccation Product Overview
Table 92. IMBCA Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. IMBCA Business Overview
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Ltd Basic Information
Table 96. Panacea Biotec Ltd Poliomyelitis Vaccation Product Overview
Table 97. Panacea Biotec Ltd Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Panacea Biotec Ltd Business Overview
Table 99. Panacea Biotec Ltd Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Poliomyelitis Vaccation Product Overview
Table 102. Bio-Med Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Basic Information
Table 106. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccation Product Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Halfkin Bio-Pharmaceuticals Business Overview
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. SINOVAC Basic Information
Table 111. SINOVAC Poliomyelitis Vaccation Product Overview
Table 112. SINOVAC Poliomyelitis Vaccation Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. SINOVAC Business Overview
Table 114. SINOVAC Recent Developments
Table 115. Global Poliomyelitis Vaccation Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Poliomyelitis Vaccation Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Poliomyelitis Vaccation Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Poliomyelitis Vaccation Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Poliomyelitis Vaccation Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Poliomyelitis Vaccation Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Poliomyelitis Vaccation Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Poliomyelitis Vaccation Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Poliomyelitis Vaccation Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Poliomyelitis Vaccation Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Poliomyelitis Vaccation Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Poliomyelitis Vaccation Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Poliomyelitis Vaccation Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Poliomyelitis Vaccation Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Poliomyelitis Vaccation Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Poliomyelitis Vaccation Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Poliomyelitis Vaccation Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Poliomyelitis Vaccation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliomyelitis Vaccation Market Size (M USD), 2025-2035
Figure 5. Global Poliomyelitis Vaccation Market Size (M USD) (2020-2035)
Figure 6. Global Poliomyelitis Vaccation Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliomyelitis Vaccation Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliomyelitis Vaccation Product Life Cycle
Figure 13. Poliomyelitis Vaccation Sales Share by Manufacturers in 2025
Figure 14. Global Poliomyelitis Vaccation Revenue Share by Manufacturers in 2025
Figure 15. Poliomyelitis Vaccation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Poliomyelitis Vaccation Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccation Revenue in 2025
Figure 18. Industry Chain Map of Poliomyelitis Vaccation
Figure 19. Global Poliomyelitis Vaccation Market PEST Analysis
Figure 20. Global Poliomyelitis Vaccation Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Poliomyelitis Vaccation Market Share by Type
Figure 27. Sales Market Share of Poliomyelitis Vaccation by Type (2020-2025)
Figure 28. Sales Market Share of Poliomyelitis Vaccation by Type in 2025
Figure 29. Market Share of Poliomyelitis Vaccation by Type (2020-2025)
Figure 30. Market Share of Poliomyelitis Vaccation by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Poliomyelitis Vaccation Market Share by Application
Figure 33. Global Poliomyelitis Vaccation Sales Market Share by Application (2020-2025)
Figure 34. Global Poliomyelitis Vaccation Sales Market Share by Application in 2025
Figure 35. Global Poliomyelitis Vaccation Market Share by Application (2020-2025)
Figure 36. Global Poliomyelitis Vaccation Market Share by Application in 2025
Figure 37. Global Poliomyelitis Vaccation Sales Growth Rate by Application (2020-2025)
Figure 38. Global Poliomyelitis Vaccation Sales Market Share by Region (2020-2025)
Figure 39. Global Poliomyelitis Vaccation Market Size by Region (2020-2025)
Figure 40. North America Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Poliomyelitis Vaccation Sales Market Share by Country in 2024
Figure 43. North America Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Poliomyelitis Vaccation Market Size by Country in 2024
Figure 45. U.S. Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Poliomyelitis Vaccation Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Poliomyelitis Vaccation Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Poliomyelitis Vaccation Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Poliomyelitis Vaccation Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Poliomyelitis Vaccation Sales Market Share by Country in 2024
Figure 53. Europe Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Poliomyelitis Vaccation Market Size by Country in 2024
Figure 55. Germany Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Poliomyelitis Vaccation Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Poliomyelitis Vaccation Sales Market Share by Region in 2024
Figure 67. Asia Pacific Poliomyelitis Vaccation Market Size by Region in 2024
Figure 68. China Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Poliomyelitis Vaccation Sales and Growth Rate (K MT)
Figure 79. South America Poliomyelitis Vaccation Sales Market Share by Country in 2024
Figure 80. South America Poliomyelitis Vaccation Market Size and Growth Rate (M USD)
Figure 81. South America Poliomyelitis Vaccation Market Size by Country in 2024
Figure 82. Brazil Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Poliomyelitis Vaccation Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Poliomyelitis Vaccation Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Poliomyelitis Vaccation Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Poliomyelitis Vaccation Market Size by Region in 2024
Figure 92. Saudi Arabia Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Poliomyelitis Vaccation Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Poliomyelitis Vaccation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Poliomyelitis Vaccation Production Market Share by Region (2020-2025)
Figure 103. North America Poliomyelitis Vaccation Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Poliomyelitis Vaccation Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Poliomyelitis Vaccation Production (K MT) Growth Rate (2020-2025)
Figure 106. China Poliomyelitis Vaccation Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Poliomyelitis Vaccation Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Poliomyelitis Vaccation Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Poliomyelitis Vaccation Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Poliomyelitis Vaccation Market Share Forecast by Type (2026-2035)
Figure 111. Global Poliomyelitis Vaccation Sales Forecast by Application (2026-2035)
Figure 112. Global Poliomyelitis Vaccation Market Share Forecast by Application (2026-2035)